A Study of Hydroxypropyl Α-Cyclodextrin and Α-Cyclodextrin Inclusion Complexity

Advancements in Cyclodextrin Synthesis and Purification

Authors

  • Pashupati Nath Sharma Research Scholar, Department of Chemistry, SSSUTMS, Sehore.

DOI:

https://doi.org/10.29070/ag4ehh15

Keywords:

cyclodextrins, enzyme, starch, CDTase, complexation, water solubility, crystallization, chromatographic techniques, complex formation, enzymatic conversion, Bacillus macerans, biotechnological advancement, drugs

Abstract

Cyclodextrins are generated with a range of readily available enzymes for the treatment of ordinary starch. Along with amylase, cyclodextrin glycosylotransferase is commonly used. The first is to liquify starch by thermal treatment or amylase and add CGTase to the enzyme conversion. The synthesis of all three types of cyclodextrins is possible at ratios that depend strictly on the enzyme used. Each CGTase has an independent synthesis relationship. Cyclodextrins are filtered according to their different water solubility CDs that are very poorly water-soluble can be easily crystallised while the more soluble - and -CDs (145 and 232 gl) normally cleaned using chromatographic techniques. Alternatively, during the enzymatic conversion, a complexing agent may be added to form a complex with the desired cyclodextrin (usually organic solvents such as toluene, acetone or ethenol). The complex formation contributes to the conversion of starch to a precipitate cyclodextrin's synthesis and hence increases the content of the final product mix. Cyclodextrins Extracting amylase starch from Bacillus macerans results in a crude cyclodextrin mixture. There were some other linear and ramified dextrins in the mix along with small quantities of proteins and other impurities. Dramatic changes to their efficiency were attributed to biotechnological advancement in the 1970s. Various forms of CGTases made by evolution have been used to produce cyclodextrins more active and precise than previously used enzymes. Along with other technical advances, these enzymes developed highly purified cyclodextrin which can be used as drugs.

References

Baudin, C, Pean, C, Perly, B &Goselin, P 2000, ‘Inclusion of organic pollutants in cyclodextrin and derivatives’, International Journal of Environmental Analytical Chemistry, vol.77, pp. 233–242.

Kumar, R, Dahiya, JS, Singh, D & Nigam, P 2001, ‘Biotransformation of cholesterol using Lactobacillus bulgaricus in a glucose-controlled bioreactor’, Bioresource Technology, vol.78, no. 2, pp. 209-211,

Koukiekolo, R, Desseaux, V, Moreau, Y, Marchis, MG &Santimone, M 2001, ‘Mechanism of porcine pancreatic -amylase, Inhibition of amylose and maltopentaose hydrolysis by α-, β- and γ-cyclodextrins’, European Journal of Biochemistry, vol.268, no.3, pp. 841-848.

Munoz-Botella, S, Castillo, BD &Martyn, MA 1995, ‘Cyclodextrin properties and applications of inclusion complex formation’, ArsPharmaceutica, vol. 36, pp. 187-198.

Schneiderman, E &Stalcup, AM 2000, ‘Cyclodextrins: a versatile tool in separation science’, Journal of Chromotography B’, vol. 745, no.1, pp. 83-102.

Connors, KA 1997, ‘The Stability of Cyclodextrin Complexes in Solution’, Chemical Reviews, vol .97, no.51, pp. 1325-1358.

Rao, VM & Stella, VJ 2003, ‘When can cyclodextrins be considered for solubilization purposes?’, Journal of Pharmaceutical sciences, vol. 92, pp. 927–932.

Loftsson, T, Olafsdottir, BJ &Frioriksdottir, H 1993, ‘Cyclodextrin complexation of NSAIDs: Physicochemical characteristics’, European Journal of Pharmaceutical Sciences, vol. 1, pp. 95-101.

Uekama, K, Hirayama, F &Irie, T 1998, ‘Cyclodextrin Drug Carrier Systems’, Chemical Reviews, vol. 98, no. 5, pp. 2045-2076.

Brewster, ME, Verreck, G, Chun, I, Rosenblatt, J, Mensch, J, Van Dijck, A, Noppe, M, Arien, A, Bruining, M &Peeters, J 2004, ‘The use of polymer-based electrospunnanofiberscontaining amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals,’ Pharmazie, vol. 59, no. 5, pp. 387-391.

Agarwal, R & Gupta, V 2012, Cyclodextrins - A review on pharmaceutical applications for drug delivery, International Journal of Pharmaceutical Research, vol. 2, no. 1, pp. 95-112.

Shimpi, S, Chauhan, B &Shimpi, P 2005, Cyclodextrins: application in different routes of drug administration, ActaPharmaceutica, vol. 55, no. 2, pp. 139-156.

Liu, L &Guo, Q 2002, ‘The driving forces in the inclusion complexation of cyclodextrins’, Journal of Inclusion Phenomena and Macrocyclic Chemistry, vol. 42, pp.1–14.

Singh, R, Bharti, N, Madan, J &Hiremath, SN 2010, ‘Characterization of Cyclodextrin Inclusion Complexes – A Review’, Journal of Pharmaceutical Science and Technology, vol. 2 no. 3, pp. 171-183.

Stella, VJ, Rao, VM, Zannou, EA & Zia, VV 1999, ‘Mechanisms of drug release from cyclodextrin complexes’, Advanced Drug Delivery Review, vol. 36, no. 1, pp. 3-16.

Wenz, G, Hofler, T, Wehrle, S & Schneider, M 1988, ‘Inclusion of pharmaceutical drugs in cyclodextrins as measured by titration microcolorimetry’, Polymer Preprints, vol. 39, pp. 202-203.

Lala, R, Thorat, A &Gargote, C 2011, ‘Current trends in cyclodextrin based drug delivery system’, International Journal of Research in Ayurveda & Pharmacy, vol. 2, no. 5, pp. 1520-1526.

Loftsson, T & Masson, M 2001, ‘Cyclodextrins in topical drug formulations: theory and practice’, International Journal of Pharmaceutics, vol. 225, no. 1–2, pp.15–30.

Loftsson, T, Brewster, ME & Masson, M 2004, ‘Role of Cyclodextrins in Improving Oral Drug Delivery’, American journal of Drug Delivery, vol. 2, no. 4, pp. 261-275.

Castillo, JA, Canales, JP, Garcia, JJ, Lastres, JL, Bolas, F &Torrado, JJ 1999. ‘Preparation and characterization of albendazole beta-cyclodextrin complexes’, Drug Development and Industrial Pharmacy, vol. 25, pp. 1241-1248.

Diaz, D, EscobarLlanos, CM &Bernad, MJB 1999, ‘Study of the binding in an aqueous medium of inclusion complexes of several cyclodextrins involving fenoprofen calcium’, Drug Development and Industrial Pharmacy, vol. 25, pp. 107-110.

Mura, P, Faucci, MT, Parrini, PL, Furlanetto, S &Pinzauti, S 1999, ‘Influence of the preparation method on the physicochemical properties of ketoprofen cyclodextrin binary systems’, International Journal of Pharmaceutics, vol. 179, pp. 117-128

Downloads

Published

2022-04-01

How to Cite

[1]
“A Study of Hydroxypropyl Α-Cyclodextrin and Α-Cyclodextrin Inclusion Complexity: Advancements in Cyclodextrin Synthesis and Purification”, JASRAE, vol. 19, no. 3, pp. 5–10, Apr. 2022, doi: 10.29070/ag4ehh15.

How to Cite

[1]
“A Study of Hydroxypropyl Α-Cyclodextrin and Α-Cyclodextrin Inclusion Complexity: Advancements in Cyclodextrin Synthesis and Purification”, JASRAE, vol. 19, no. 3, pp. 5–10, Apr. 2022, doi: 10.29070/ag4ehh15.